Chimerix Inc (CMRX)
0.891
-0.02
(-1.66%)
USD |
NASDAQ |
Apr 25, 16:00
0.892
0.00 (0.00%)
After-Hours: 20:00
Chimerix Total Liabilities (Quarterly): 19.74M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 19.74M |
| September 30, 2023 | 16.98M |
| June 30, 2023 | 16.97M |
| March 31, 2023 | 18.22M |
| December 31, 2022 | 22.48M |
| September 30, 2022 | 19.93M |
| June 30, 2022 | 25.64M |
| March 31, 2022 | 17.72M |
| December 31, 2021 | 32.29M |
| September 30, 2021 | 28.82M |
| June 30, 2021 | 27.58M |
| March 31, 2021 | 25.00M |
| December 31, 2020 | 11.35M |
| September 30, 2020 | 10.34M |
| June 30, 2020 | 8.538M |
| March 31, 2020 | 6.728M |
| December 31, 2019 | 9.424M |
| September 30, 2019 | 15.80M |
| June 30, 2019 | 14.32M |
| March 31, 2019 | 13.68M |
| December 31, 2018 | 13.11M |
| September 30, 2018 | 9.552M |
| June 30, 2018 | 9.587M |
| Date | Value |
|---|---|
| March 31, 2018 | 9.207M |
| December 31, 2017 | 13.42M |
| September 30, 2017 | 9.186M |
| June 30, 2017 | 8.014M |
| March 31, 2017 | 9.033M |
| December 31, 2016 | 10.55M |
| September 30, 2016 | 9.903M |
| June 30, 2016 | 10.83M |
| March 31, 2016 | 10.54M |
| December 31, 2015 | 20.53M |
| September 30, 2015 | 21.30M |
| June 30, 2015 | 22.20M |
| March 31, 2015 | 16.60M |
| December 31, 2014 | 17.24M |
| September 30, 2014 | 17.40M |
| June 30, 2014 | 13.98M |
| March 31, 2014 | 12.53M |
| December 31, 2013 | 14.85M |
| September 30, 2013 | 15.03M |
| June 30, 2013 | 15.51M |
| March 31, 2013 | 28.48M |
| December 31, 2012 | 25.34M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
6.728M
Minimum
Mar 2020
32.29M
Maximum
Dec 2021
18.31M
Average
17.72M
Median
Mar 2022
Total Liabilities (Quarterly) Benchmarks
| UFP Technologies Inc | 118.04M |
| Dentsply Sirona Inc | 4.076B |
| Arbutus Biopharma Corp | 38.38M |
| Pacira BioSciences Inc | 704.26M |
| Karyopharm Therapeutics Inc | 376.64M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 212.77M |
| Shareholders Equity (Quarterly) | 193.03M |
| Debt to Equity Ratio | 0.0006 |
| Current Ratio | 10.25 |
| Net Debt Paydown Yield | 0.03% |